Impacts of18F-FDG PET/CT Parameters on Differential Diagnosis and Outcome of Patients with Primary Invasive Mucinous and Lepidic Predominant Adenocarcinoma of the Lung 18 F-FDG PET/BT Parametrelerinin Primer İnvaziv Müsinöz ve Lepidik Baskın Akciğer Adenokarsinomlu Hastaların Ayırıcı Tanısı ve Sonuçları Üzerindeki Etkileri


TATCI E., ÖZMEN Ö., Kızılgöz D., DEMİRAĞ F., BİLGİÇ S.

Molecular Imaging and Radionuclide Therapy, cilt.33, sa.3, ss.147-155, 2024 (ESCI, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 3
  • Basım Tarihi: 2024
  • Doi Numarası: 10.4274/mirt.galenos.2024.24571
  • Dergi Adı: Molecular Imaging and Radionuclide Therapy
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.147-155
  • Anahtar Kelimeler: primary invasive mucinous adenocarcinoma of the lung, lepidic predominant adenocarcinoma of the lung, 18F-FDG 18 F-FDG PET/CT
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objectives: The purpose of this study was to investigate whether18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) parameters have a role in differentiating invasive mucinous lung adenocarcinoma (IMA) from lepidic predominant lung adenocarcinoma (LPA). Additionally, we compared the18F-FDG-PET/CT features between survivors and non-survivors. Methods: Tumors were divided into 2 groups according to CT appearance: Group 1: nodular-type tumor; group 2: mass-or pneumonic-type tumor. Unilateral and bilateral multifocal diseases were detected. Clinicopathological characteristics and PET/CT findings were compared between IMAs and LPAs, as well as between survivors and non-survivors. Results: We included 43 patients with IMA and 14 with LPA. Tumor size (p=0.003), incidence of mass/pneumonic type (p=0.011), and bilateral lung involvement (p=0.049) were higher in IMAs than in LPAs. IMAs had more advanced T, M, and Tumor, Node, and Metastasis stages than in LPAs (p=0.048, p=0.049, and p=0.022, respectively). There was no statistically significant difference in maximum standardized uptake value (SUVmax) between the IMA and LPA (p=0.078). The SUV was significantly lower in the nodular group than in the mass/pneumonic-type group (p=0.0001). A total of 11 patients died, of whom SUVmax values were significantly higher in these patients (p=0.031). Male gender (p=0.0001), rate of stage III-IV (p=0.0001), T3-T4 (p=0.021), M1 stages (p=0.0001), multifocality (p=0.0001), and bilateral lung involvement (p=0.0001) were higher in non-survivor. Conclusions: Although CT images were useful for the differential diagnosis of LPAs and IMAs, SUVmax was not helpful for differentiation of these 2 groups. However, both18F-FDG uptake and CT findings may play an important role in predicting prognosis in these patients.